RT Book, Section
A1 O’Donnell, James M.
A1 Bies, Robert R.
A1 Williams, Aislinn J.
A2 Brunton, Laurence L.
A2 Knollmann, Björn C.
SR Print(0)
ID 1193229416
T1 Drug Therapy of Depression and Anxiety Disorders
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264258079
LK accessmedicine.mhmedical.com/content.aspx?aid=1193229416
RD 2024/04/24
AB Depression  and  anxiety  disorders  are  the  most  common  mental  illnesses,  each  affecting  in  excess  of  15%  of  the  population  at  some  point  in  the  life  span.  With  the  advent  of  more  selective  and  safer  drugs,  the  use  of  antidepressants  and  anxiolytics  has  moved  from  the  exclusive  domain  of  psychiatry  to  primary  care  and  other  medical  specialties.  The  relative  safety  of  the  majority  of  commonly  used  antidepressants  and  anxiolytics  notwithstanding,  their  optimal  use  requires  a  clear  understanding  of  their  mechanisms  of  action,  pharmacokinetics,  adverse  effects,  potential  drug  interactions,  and  the  differential  diagnosis  of  psychiatric  illnesses  (Thronson  and  Pagalilauan,  2014).